Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

13 Résultats de recherche.
Pertinence Commentaire Plus récent Moins récent

Eligibility Treatment-resistant Depression NCT02360280

- 20/09/2021 - 1 Formulaire, 2 Groupes Item, 16 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Efficacy of Repeated Ketamine Infusions for Treatment-resistant Depression; ODM derived from: https://clinicaltrials.gov/show/NCT02360280

Eligibility Treatment-resistant Depression NCT02497287

- 27/07/2019 - 1 Formulaire, 2 Groupes Item, 12 Eléments de données, 1 Langue
Groupes Item: Criteria, Exclusion Criteria
A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression; ODM derived from: https://clinicaltrials.gov/show/NCT02497287

Eligibility Treatment-resistant Depression NCT02493868

- 27/07/2019 - 1 Formulaire, 2 Groupes Item, 12 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression; ODM derived from: https://clinicaltrials.gov/show/NCT02493868

Eligibility Treatment-resistant Depression NCT02422186

- 27/07/2019 - 1 Formulaire, 2 Groupes Item, 15 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression; ODM derived from: https://clinicaltrials.gov/show/NCT02422186

Eligibility Treatment-resistant Depression NCT02418585

- 27/07/2019 - 1 Formulaire, 2 Groupes Item, 10 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression; ODM derived from: https://clinicaltrials.gov/show/NCT02418585

Eligibility Treatment Resistant Depression NCT01353092

- 23/01/2019 - 1 Formulaire, 2 Groupes Item, 10 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Pulsating ElectroMagnetive Treatment (PEMF) at Treatment Resistant Depression; ODM derived from: https://clinicaltrials.gov/show/NCT01353092

Eligibility Depressive Disorder, Treatment-Resistant NCT01983904

- 17/12/2018 - 1 Formulaire, 2 Groupes Item, 8 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
DBS for Treatment Resistant Depression; ODM derived from: https://clinicaltrials.gov/show/NCT01983904

Eligibility Treatment Resistant Depression NCT00646087

- 08/11/2018 - 1 Formulaire, 2 Groupes Item, 19 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Ketamine Frequency Treatment for Major Depressive Disorder; ODM derived from: https://clinicaltrials.gov/show/NCT00646087

Eligibility Therapy-Resistant Depression DRKS00000021 NCT00273624 - Eligibility Therapy-Resistant Depression NCT00273624

- 28/06/2017 - 1 Formulaire, 2 Groupes Item, 9 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Olanzapine Augmentation Therapy in Treatment-Resistant Depression: a Double-Blind Placebo-Controlled Trial; ODM derived from: https://clinicaltrials.gov/show/NCT00273624

Eligibility Therapy-resistant Depression NCT00276978

- 28/06/2017 - 1 Formulaire, 2 Groupes Item, 9 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Aripiprazole Augmentation Therapy in Treatment-resistant Depression; ODM derived from: https://clinicaltrials.gov/show/NCT00276978

Eligibility Depressive Disorder, Treatment-Resistant NCT01179009

- 28/02/2016 - 1 Formulaire, 2 Groupes Item, 20 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Treatment Resistant Depression (Pilot); ODM derived from: https://clinicaltrials.gov/show/NCT01179009

Eligibility Major Depressive Disorder NCT00533832

- 24/01/2016 - 1 Formulaire, 2 Groupes Item, 34 Eléments de données, 1 Langue
Groupes Item: Inclusion Criteria, Exclusion Criteria
Pivotal Trial (D02) of Vagus Nerve Stimulation (VNS) for Treatment-Resistant Depression (TRD); ODM derived from: https://clinicaltrials.gov/show/NCT00533832

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial